FREE ELECTRONIC LIBRARY - Books, dissertations, abstract

Pages:     | 1 |   ...   | 15 | 16 || 18 | 19 |   ...   | 34 |

«2013 Annual Report breakthrough technologies and services focused on Dear Fellow Shareholders, addressing specific customer and market needs. Several ...»

-- [ Page 17 ] --

Financing Lease Obligations. In September 2012, we entered into agreements with the lessors of buildings that we are currently occupying and leasing to expand those buildings. We provided a portion of the funds needed for the construction of the additions to the buildings, which resulted in us being considered the owner of the buildings during the construction period. At the end of the construction period, we will not be reimbursed by the lessors for all of the construction costs. We are therefore deemed to have continuing involvement and the leases will qualify as financing leases under sale-leaseback accounting guidance, representing debt obligations for us and non-cash investing and financing activities. As a result, we capitalized $29.3 million in property and equipment, net, representing the fair value of the buildings with a corresponding increase to debt. We have also capitalized $11.5 million in additional construction costs necessary to complete the renovations to the buildings, which were funded by the lessors, with a corresponding increase to debt. At December 29, 2013, we had $40.3 million recorded for these financing lease obligations, of which $2.6 million was recorded as short-term debt and $37.7 million was recorded as long-term debt. At December 30, 2012, we had $34.6 million recorded for these financing lease obligations, of which $1.7 million was recorded as short-term debt and $32.9 million was recorded as long-term debt. The buildings are being depreciated on a straight-line basis over the terms of the leases to their estimated residual values, which will equal the remaining financing obligation at the end of the lease term. At the end of the lease term, the remaining balances in property, plant and equipment, net and debt will be reversed against each other.

Dividends Our Board declared a regular quarterly cash dividend of $0.07 per share in each quarter of fiscal years 2013 and 2012, resulting in an annual dividend rate of $0.28 per share. At December 29, 2013, we had accrued $7.9 million for dividends declared on October 24, 2013 for the fourth quarter of fiscal year 2013, payable in February

2014. On January 24, 2014, we announced that our Board had declared a quarterly dividend of $0.07 per share for the first quarter of fiscal year 2014 that will be payable in May 2014. In the future, our Board may determine to reduce or eliminate our common stock dividend in order to fund investments for growth, repurchase shares or conserve capital resources.

–  –  –

(1) The credit facility borrowings carry variable interest rates; the amount included in this table does not include interest obligations. On January 8, 2014, we refinanced our debt held under the senior unsecured revolving credit facility and entered into a new senior unsecured revolving credit facility, with an initial maturity of January 8, 2019.

(2) The 2021 Notes include interest obligations.

(3) As of December 29, 2013 the 2021 Notes had a carrying value of $497.4 million.

(4) We do not expect to cash settle any uncertain tax positions during fiscal year 2014. We have excluded $20.2 million, including accrued interest, net of tax benefits, and penalties, from the amount related to our uncertain tax positions as we cannot make a reasonably reliable estimate of the amount and period of related future payments.

Capital Expenditures During fiscal year 2014, we expect to invest an amount for capital expenditures similar to that in fiscal year 2013, primarily to introduce new products, to improve our operating processes, to shift the production capacity to lower cost locations, and to develop information technology. We expect to use our available cash and internally generated funds to fund these expenditures.

Other Potential Liquidity Considerations At December 29, 2013, we had cash and cash equivalents of $173.2 million, of which $168.6 million was held by our non-U.S. subsidiaries, and we had $291.0 million of additional borrowing capacity available under a senior unsecured revolving credit facility. We had no other liquid investments at December 29, 2013.

We utilize a variety of tax planning and financing strategies to ensure that our worldwide cash is available in the locations in which it is needed. Of the $168.6 million of cash and cash equivalents held by our non-U.S. subsidiaries at December 29, 2013, we would incur U.S. taxes on approximately $145.0 million if transferred to the U.S. without proper planning. We expect the remaining accumulated non-U.S. cash balances, that may not be transferred to the U.S.

without incurring U.S. taxes, will remain outside of the U.S. and that we will meet U.S. liquidity needs through future cash flows, use of U.S. cash balances, external borrowings, or some combination of these sources.

On October 24, 2012, our Board authorized us to repurchase up to 6.0 million shares of common stock under a stock repurchase program (the “Repurchase Program”). The Repurchase Program will expire on October 24, 2014 unless terminated earlier by our Board, and may be suspended or discontinued at any time.

During fiscal year 2013, we repurchased approximately 3.6 million shares of common stock in the open market at an aggregate cost of $123.0 million, including commissions, under the Repurchase Program. As of December 29, 2013, approximately 2.4 million shares authorized by our Board under the Repurchase Program remained available for repurchase.

Our Board has authorized us to repurchase shares of common stock to satisfy minimum statutory tax withholding obligations in connection with the vesting of restricted stock awards and restricted stock unit awards granted pursuant to our equity incentive plans. During fiscal year 2013, we repurchased 127,544 shares of common stock for this purpose at an aggregate cost of $4.4 million.

The repurchased shares have been reflected as a reduction in shares outstanding, but remain available to be reissued with the payments reflected in common stock and capital in excess of par value. Any repurchased shares will be available for use in connection with corporate programs. If we continue to repurchase shares, the Repurchase Program will be funded using our existing financial resources, including cash and cash equivalents, and our existing senior unsecured revolving credit facility.

Distressed global financial markets could adversely impact general economic conditions by reducing liquidity and credit availability, creating increased volatility in security prices, widening credit spreads and decreasing valuations of certain investments. The widening of credit spreads may create a less favorable environment for certain of our businesses and may affect the fair value of financial instruments that we issue or hold. Increases in credit spreads, as well as limitations on the availability of credit at rates we consider to be reasonable, could affect our ability to borrow under future potential facilities on a secured or unsecured basis, which may adversely affect our liquidity and results of operations. In difficult global financial markets, we may be forced to fund our operations at a higher cost, or we may be unable to raise as much funding as we need to support our business activities.

Our pension plans have not experienced a material impact on liquidity or counterparty exposure due to the volatility and uncertainty in the credit markets. With respect to plans outside of the United States, we expect to contribute $11.1 million in the aggregate during fiscal year 2014. We could potentially have to make additional funding payments in future periods for all pension plans. During fiscal year 2013, we made contributions of $37.0 million for the 2012 plan year to our defined benefit pension plan in the United States. During fiscal year 2013, we contributed $20.2 million, in the aggregate, to plans outside of the United States, which includes an additional contribution of $10.0 million to our defined benefit pension plan in the United Kingdom. During fiscal year 2012, we made a contribution of $17.0 million for the 2011 plan year to our defined benefit pension plans in the United States, and $10.9 million in the aggregate to our defined benefit pension plans outside of the United States. We expect to use existing cash and external sources to satisfy future contributions to our pension plans.

We entered into a strategic agreement in fiscal year 2012 under which we acquired certain intangible assets and received a license to certain core technology for an analytics and data discovery platform, as well as the exclusive right to distribute the platform in certain scientific research and development markets. During fiscal year 2012, we paid $6.8 million for net intangible assets and $25.0 million for prepaid royalties. During fiscal year 2013, we extended the existing agreement for an additional year. In addition, we entered into a new agreement to expand the distribution rights to the clinical and other related markets and acquired additional intangible assets. During fiscal year 2013, we paid $7.0 million for net intangible assets and $40.3 million for prepaid royalties. We do not expect to pay any additional prepaid royalties within the next twelve months. We expense royalties as revenue is recognized.

On August 22, 2013, we sold one of our facilities located in Boston, Massachusetts for net proceeds of $47.6 million. Simultaneously with the closing of the sale of the property, we entered into a lease agreement to lease back the property for our continued use. The lease has an initial term of 15 years and we have the right to extend the term of the lease for two additional periods of ten years each. The lease is accounted for as an operating lease and we have deferred $26.5 million of gains which will be amortized in operating expenses over the initial lease term of 15 years. During fiscal year 2013, we amortized $0.6 million of deferred gains related to the lease. At December 29, 2013, $25.9 million of these deferred gains remained to be amortized.

Effects of Recently Adopted Accounting Pronouncements During the first quarter of fiscal year 2013 we adopted new guidance on additional disclosure requirements of other comprehensive income. This new guidance requires the presentation of reclassifications out of accumulated other comprehensive income on the face of the financial statements or as a separate disclosure in the notes to the financial statements. The reclassifications out of accumulated other comprehensive income and into net income were not material for fiscal years 2013, 2012 or 2011. See Note 19 to our consolidated financial statements included in this annual report on Form 10-K for additional details.

Effects of Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”) and are adopted by us as of the specified effective dates. We believe that the impact of recently issued pronouncements will not have a material impact on our consolidated financial position, results of operations, and cash flows or do not apply to our operations.

Application of Critical Accounting Policies and Estimates The preparation of consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, warranty costs, bad debts, inventories, accounting for business combinations and dispositions, long-lived assets, income taxes, restructuring, pensions and other postretirement benefits, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

We believe the following critical accounting policies affect our more significant judgments and estimates used in preparation of our consolidated financial statements.

Pages:     | 1 |   ...   | 15 | 16 || 18 | 19 |   ...   | 34 |

Similar works:

«UK Standards for Microbiology Investigations Investigation of intravascular cannulae and associated specimens Issued by the Standards Unit, Microbiology Services, PHE Bacteriology | B 20 | Issue no: 6 | Issue date: 30.11.15 | Page: 1 of 24 © Crown copyright 2015 Investigation of intravascular cannulae and associated specimens Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the...»

«JVI Accepts, published online ahead of print on 15 November 2006 J. Virol. doi:10.1128/JVI.02122-06 Copyright © 2006, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. 1 THE HIV-1 MATRIX PROTEIN ASSEMBLES ON MEMBRANES AS A HEXAMER Ayna Alfadhli1, Doug Huseby1,2, Eliot Kapit1, Dalbinder Colman1, and Eric Barklis1,* D 5 1 Vollum Institute and Department of Molecular Microbiology and Immunology, Oregon Health 6 & Sciences University, Portland, OR, USA...»

«ESSEX HEALTH PROTECTION UNIT Part of the INFECTION CONTROL GUIDELINES FOR FUNERAL DIRECTORS Issued July 2004 Revised November 2005, February 2008 and March 2009 Contents SECTION A – INTRODUCTION AND CONTACTS 1 1. Introduction 1 2. Contact List 2 SECTION B – INFECTION, ITS CAUSES AND SPREAD 3 1. Infection and its Control 3 SECTION C – STANDARD PRINCIPLES OF INFECTION CONTROL 5 1. Standard Principles of Infection Control (Universal Precautions) 5 SECTION D – MANAGEMENT OF SHARPS INJURIES...»

«ANGEL My Course Submission and Consultation Printable Webpage Page 1 of 9 SENATE COMMITTEE ON CURRICULAR AFFAIRS COURSE SUBMISSION AND CONSULTATION FORM Principal Faculty Member Proposing Course: Aaron Mauro College: BEHREND COLLEGE Department or Instructional Area: HUMANITIES AND SOCIAL SCIENCES College/Academic Unit With Curriculum Responsibility: BEHREND COLLEGE Type of Proposal: Add Change Drop Type of Review: Full Expedited (See Guide to Curricular Procedure for definitions of a full or...»

«UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT FAIRFIELD COUNTY MEDICAL ASSOCIATION, et al., Plaintiffs, No. 3:13-cv-1621 (SRU) v. UNITED HEALTHCARE OF NEW ENGLAND, et al., Defendants. RULING AND ORDER GRANTING PLAINTIFFS’ MOTION FOR A TEMPORARY RESTRAINING ORDER AND PRELIMINARY INJUNCTION On November 15, 2013, plaintiffs Fairfield County Medical Association and Hartford County Medical Association, Inc.1 (collectively ―the Associations‖), submitted their emergency motion for a...»

«Abteilung für Sportorthopädie der Technische Universität München Klinikum rechts der Isar (Leiter: Univ.-Prof. Dr. A. Imhoff) Effekt von Bone Morphogenetic Protein 2 auf die Knorpel/Knochenregeneration am Kaninchenmodell Histologische und Immunhistologische Ergebnisse Daniel Hensler Vollständiger Abdruck der von der Fakultät für Medizin der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Medizin genehmigten Dissertation. Vorsitzender: Univ.-Prof....»

«Die Genauigkeit der menschlichen Hand im Vergleich mit einem Mikromanipulatorpräklinische Evaluation für die Ohrchirurgie Dissertation zur Erlangung des akademischen Grades Dr. med. an der medizinischen Fakultät der Universität Leipzig eingereicht von: Runge, Annette, geb. May Geboren am 16.08.1984 in Dresden angefertigt an der: Universität Leipzig, Medizinische Fakultät Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Plastische Operationen und dem Innovation Center Computer...»

«-ITECHNISCHE UNIVERSITÄT MÜNCHEN Klinik für Psychiatrie und Psychotherapie Klinikum rechts der Isar (Direktor: Univ.-Prof. Dr. J. Förstl) Validierung des deutschen Examinati Addenbrooke´s Cognitive Examination (ACERevised (ACE-R) Elvira Schöll Vollständiger Abdruck der von der Fakultät für Medizin der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Medizin genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr. E. J. Rummeny Prüfer der...»

«200/SNEK XXV. GP Stellungnahme zu Enquete-Kommission Würde am Ende des Lebens 1 von 6 Sehr geehrte Damen und Herren! Im Zusammenhang mit der derzeit laufenden Sterbehilfe-Debatte darf ich Ihnen die Stellungnahme der Arbeitsgruppe Ethik der Österreichischen Gesellschaft für Anästhesie, Reanimation und Intensivmedizin übermitteln, die am 13.4.2014 veröffentlicht wurde und damals bereits Mag. Aubauer sowie den den Parlamentsklubs zugegangen ist. Sie ist zudem auf der Aktuell-Seite der...»

«Aus der Universitätsklinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin Campus Charité Mitte und Campus Virchow Klinikum der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Untersuchung des Einflusses von C1-Esterase-Inhibitor in Kombination mit Faktor XIII auf die funktionelle Kapillardichte und die Leukozytenadhärenz in der intestinalen Mikrozirkulation bei experimenteller Endotoxinämie Zur Erlangung des akademischen Grades Doctor medicinae...»

<<  HOME   |    CONTACTS
2016 www.book.dislib.info - Free e-library - Books, dissertations, abstract

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.